Glucose Sterile Concentrate B. Braun Medical (Glucose, Anhydrous)

Glucose Sterile Concentrate is indicated for several clinical situations where rapid intravenous glucose delivery is required.

• Carbohydrate source in total or supplemental parenteral nutrition formulations.
• Treatment of documented hypoglycemia when oral glucose is not feasible.
• Component of fluid and electrolyte replacement solutions that provide caloric support.
• Maintenance of blood glucose levels during intraoperative or postoperative care.
• Dilution medium for certain intravenous medications that require a glucose carrier.

When administered intravenously, glucose solutions may be associated with predictable physiological responses and, rarely, more serious complications.

Common

• Transient hyperglycemia.
• Local irritation at the infusion site.
• Mild electrolyte shifts, such as changes in sodium or potassium levels.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hypoglycemia after abrupt discontinuation of the infusion.
• Fluid overload or pulmonary edema in patients with compromised cardiac or renal function.
• Allergic or anaphylactic reaction to the solution components.

Clinicians should evaluate patient-specific factors and monitor parameters to minimize risks associated with intravenous glucose administration.

• Assess baseline blood glucose and adjust infusion rate accordingly.
• Monitor for signs of fluid overload, especially in patients with cardiac or renal impairment.
• Use caution in patients with uncontrolled diabetes mellitus or insulin resistance.
• Verify compatibility with other IV drugs before co‑administration.
• Avoid rapid infusion rates that exceed recommended osmolarity limits.
• Consider electrolyte status, particularly potassium and phosphate, before initiating therapy.

Glucose Sterile Concentrate can interact with other intravenous agents, affecting stability or metabolic outcomes.

Avoid

• Co‑administration with high‑dose insulin infusions without appropriate glucose monitoring.
• Mixing with calcium‑containing solutions that may precipitate.
• Concurrent use of drugs that cause hyperglycemia (e.g., corticosteroids) without dose adjustment.

Use with caution

• Concurrent administration of potassium chloride solutions, as glucose can drive potassium into cells.
• Use alongside diuretics that alter fluid balance, requiring close monitoring.
• Combination with other carbohydrate‑containing fluids, which may increase total caloric load.